RT-20
RT-20 contains 20 mg retatrutide research material. Retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist and, as of August 2026, is not approved by any regulatory agency.
- Product
- RT-20
- Quantity
- 20 mg retatrutide
- Form
- Lyophilized research material - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-RT-20
For research use only.
Not for human or veterinary consumption.
RT-20 / 20 mg retatrutide
Retatrutide / LY3437943 is presented as 20 mg retatrutide for laboratory research use. Product specifications and any available documentation are provided on this page.
Research context: Receptor pharmacology, triple-agonist signaling, ligand characterization, analytical peptide chemistry, in vitro pathway research.
Product data
- Compound
- Retatrutide / LY3437943
- Quantity
- 20 mg retatrutide
- Category
- Peptide Research Reagents
- Form
- Lyophilized research material - verify Syntide COA
- Presentation
- Vial
- SKU
- SA-RT-20
Quality & documentation
Available files are shown from the current documentation record for this product. Availability may vary by product or batch.
Available where provided
Documentation for this product is not currently available online. Contact support for assistance.
Order information
Shipping
Orders are processed according to the Syntide Aminos Shipping Policy.
Research catalog
Explore additional compounds and supplies within the Syntide Aminos research catalog.
BPC-157
10 mg
$70.00
GHK-CU
50 mg
$70.00
IGF-1 LR3
1 mg
$70.00
KISSPEPTIN
10 mg
$70.00
RESEARCH USE NOTICE
Products offered by Syntide Aminos are intended solely for laboratory and research purposes. They are not intended for human or veterinary consumption and are not intended to diagnose, treat, cure or prevent any disease.
Product information provided on this website is for identification, specification and research-reference purposes only and should not be interpreted as medical advice or instructions for human use.
READ FULL RESEARCH USE DISCLAIMER